Importantly, WTAP upregulates PD-L1 expression through m6A-dependent mechanisms in the tumor immune microenvironment, while IGF2BP2 stabilizes the methylated PD-L1 transcript, reinforcing its accumulation and immunosuppression. This evidence concerns the gene IGF2BP2 and neoplasm.